Education
digital pharma education
SURVEYS, STUDIES, AND INTERVIEWS WITH INDUSTRY THOUGHT LEADERS
Featured Research
March 2025
This DHC Group industry conversation featured experts from LiveWorld, HealthLink Dimensions, and Assertio Therapeutics exploring the role of Nurse Practitioners (NPs) and Physician Assistants (PAs) as a segment of HCP strategy for pharmaceutical marketers. With approximately 560,000 NPs and PAs collectively writing 29% of all U.S. prescriptions—amounting to 1.2 billion prescriptions annually— pharmaceutical marketers may want to learn more about this audience before designing any comprehensive HCP marketing approach.
October & December 2024
We are in the middle of an ongoing data-driven revolution in the pharmaceutical industry. Data and analytics are reshaping how companies approach sales and marketing strategies – and customer experience. As customer expectations increase, the importance of leveraging data to drive decision-making, personalizing customer engagement, and optimizing marketing spend has never been more critical. This shift towards data-centric management is not just a trend but a strategic imperative for reducing costs and gaining a competitive edge in an increasingly complex market landscape.
These roundtables on data innovation will explore how pharmaceutical companies are harnessing the power of data for identity solutions, enhanced targeting, and exploring the potential of the integration of physician and consumer data. Our distinguished panel of thought leaders will share their experiences, challenges, and visions for the future.
September 2024
In today’s increasingly digital landscape, social strategy has shifted to reflect an undeniable truth: everyone uses social media—even healthcare providers. And healthcare providers are not just consuming content—some are even creating it.
This DHC Group project examines the progression from sourcing HCP influencers to integrating the influencers and content with the overall brand strategy and measuring success over time. Drawing on HCP research conducted by Sermo and LiveWorld, as well as a series of thought leader interviews, this industry POV is the authoritative resource for marketers looking to incorporate HCP Social Influencer efforts into a larger plan.
April 2024
In our 2023 Year End Trends industry survey, Customer Experience topped the list of trends pharma marketers are most interested in for 2024. In response, The DHC Group assembled a group of leading industry experts to study Patient Customer Experience in pharma.
Pharma industry research and consumer data were collected in partnership with Qualtrics and Sermo. Those results were shared and used by a dynamic group of partners in presentation of best practices for key facets of patient customer experience.
March 2024
This project reviews innovative approaches and strategies linking pharmacies (retail, specialty, independent) and pharma companies/brands based on exclusive data collected by The DHC Group, Sermo, and MARS Consumer Health via M3 MI.
Collective leading edge experts provide an industry guide to the innovation that’s possible at the pharmacy now – both patient and pharmacist-facing – as well as a clearer picture of what is coming
JANUARY 2024
As GenAI evolves at a record pace, pharma commercial teams must keep pace without losing sight of the overall business strategy. Understanding, testing, and extracting value from GenAI is critical for the majority of commercial teams across the pharmaceutical, bio, and life sciences landscape today.
The potential impact of GenAI within pharma ranges from MLR, creative, audience building, targeting, patient support programs, field force content optimization, as well as the broader category of customer experience programs with both patients and physicians
Insights
The Digital Health Coalition partners with our network of pharmaceutical industry leaders and key stakeholders, to facilitate and disseminate insights on a range of topics related to digital pharmaceutical marketing innovation.
Sign up to receive educational announcements from the DHC